Overview

The Pittsburgh Schizophrenia Conference is typically an annual in person meeting at which the advances in schizophrenia research and treatment are reviewed by experts in the field. This year’s meeting will be in person at the Sheraton Station Square.

Learning Objectives

At the completion of this program, participants should be able to:

1. Review the potential clinical benefits of muscarinic acetylcholine receptor agonists for treating the core symptoms of schizophrenia. The history as well as the molecular, cellular and neurocircuit mechanisms of action of this novel class of antipsychotic medicine will also be reviewed.
2. Effectively integrate, weigh, and critique the various relationships between cannabinoid exposure and psychosis outcomes and apply the knowledge about the risks of psychosis with exposure to cannabinoids in their clinical practice.
3. Increase their understanding of the implications improving behavioral health outcomes through enhanced and focused medical management.
4. Review and gain knowledge on the potential benefits of treating cognitive impairments in persons with schizophrenia.
5. Compare preceding mental health-related diagnoses, prescription drug use, and behavioral health services utilization in adolescent and young adult patients diagnosed with a first episode of Schizophrenia vs. those with Major Depressive Disorder.

Target Audience

The conference is designed to disseminate the latest clinical and research findings to a wide audience: psychiatrists and other mental health clinicians, including nurses, social workers, psychologists, service coordinators, researchers, patients and their relatives, mental health policy administrators and others who intend to keep current regarding treatment and research in schizophrenia.

Accreditation

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.